BioAdaptives Inc
BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers Human Clinical trial; Zeranovia, a natural ingredient and uses proprietary methods of optimizing the availability of nutrients in foods and beverages; Lung Flute, a … Read more
BioAdaptives Inc (BDPT) - Total Liabilities
Latest total liabilities as of September 2025: $1.59 Million USD
Based on the latest financial reports, BioAdaptives Inc (BDPT) has total liabilities worth $1.59 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
BioAdaptives Inc - Total Liabilities Trend (2013–2024)
This chart illustrates how BioAdaptives Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
BioAdaptives Inc Competitors by Total Liabilities
The table below lists competitors of BioAdaptives Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Technoplus Ventures Ltd
TA:TNPV
|
Israel | ILA25.09 Million |
|
NHK SPRING (NHK.SG)
STU:NHK
|
Germany | €271.72 Billion |
|
Focus Home Interactive Société anonyme
STU:0HF
|
Germany | €222.14 Million |
|
Amphastar Pharmaceuticals Inc
STU:29A
|
Germany | €778.18 Million |
|
ROLLS-ROYCE HLDGS
MU:RRU
|
Germany | €35.14 Billion |
|
R STAHL N
BE:RSL2
|
Germany | €204.47 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down BioAdaptives Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 12.78 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BioAdaptives Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BioAdaptives Inc (2013–2024)
The table below shows the annual total liabilities of BioAdaptives Inc from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $1.73 Million | -1.42% |
| 2023-12-31 | $1.75 Million | +17.59% |
| 2022-12-31 | $1.49 Million | +19.91% |
| 2021-12-31 | $1.24 Million | -11.16% |
| 2020-12-31 | $1.40 Million | +61.75% |
| 2019-12-31 | $864.09K | +7.50% |
| 2018-12-31 | $803.80K | +1385762.07% |
| 2017-12-31 | $58.00 | -99.98% |
| 2016-12-31 | $322.92K | +53.36% |
| 2015-12-31 | $210.56K | +197.08% |
| 2014-12-31 | $70.88K | +122.61% |
| 2013-12-31 | $31.84K | -- |